Emergency Medicine Cardiac Research and Education Group




ACTION Registry
ACTION Registry®–GWTG™ is a national, risk-adjusted, outcomes-based quality improvement program that helps participating facilities measure and improve care for high-risk ACS patients with STEMI and NSTEMI. The result of the collaboration between the two leading national coronary artery disease registries, the NCDR® ACTION Registry® and the American Heart Association (AHA) Get With The GuidelinesSM-CAD Registry, ACTION Registry–GWTG will be the largest, most comprehensive national cardiovascular patient database ever developed by the medical profession.

Combining the strengths of the two programs, ACTION Registry–GWTG will collect a comprehensive set of data elements that provide healthcare professionals and their facilities with the information they need to monitor and improve adherence to the most current, science-based ACC/AHA treatment guidelines. Participation will greatly facilitate quality improvement efforts, optimize clinical care, and improve clinical outcomes for acute coronary syndrome patients.

Visit How To Join to request additional information or to download an enrollment package. Or, visit the ACTION website for more information.


W. Brian Gibler, MD, founded the Emergency Medicine Cardiac Research Education Group (EMCREG™) in 1989 to conduct multi-center clinical research trials on serum markers for the early diagnosis of acute myocardial infarction (AMI). In 1998, EMCREG became an international collaboration of 18 physician-investigators representing 15 leading institutions throughout the world dedicated to research and education in the field of Emergency Cardiac Care. Since then, EMCREG has evolved into an international research and education network boasting 44 international academic researchers from 31 leading academic research facilities. EMCREG remains centrally coordinated through the University of Cincinnati Department of Emergency Medicine.

The strong reputations of our academic research constituency have helped to make the past year extremely productive in both our educational and research missions. At the end of 2004 EMCREG will have held its 13th educational satellite symposia over the past six years. The success of these events has raised EMCREGs reputation as an educational force to a level wherein our presence at annual scientific meetings has become an expectation of the emergency physician community. A notable change to the group’s focus has been the inclusion of neurovascular emergencies to our focus. With the recent advancements in the diagnosis and treatment of these conditions, combined with the University of Cincinnati’s reputation and strength in this field, it was a natural progression – met with enthusiasm by both our constituents and our audiences.

Our educational outreach has been further extended with an increasing number of professional quality educational monographs and hot-topics CME publications. The dramatic increase in emergency cardiovascular and neurovascular research and advancements has opened the door to a floodgate of educational opportunities fueled by a proportional increase in physician interest to keep current. Each educational piece we produce is delivered to the entire constituency of the American College of Emergency Physicians which averages 24,000 emergency physician members. In an effort to broaden our education impact, EMCREG is considering extending its outreach to the European emergency medicine community and the nursing legions of the Emergency Nurses Association.

An important mission of EMCREG has also been promoting the collaboration with other specialties in the arenas of both academic research and clinical practice. EMCREG has developed strong relationships with companion thought-leaders in both cardiology and neurology. These collaboration have involved collaborations on educational symposia, quality assurance initiatives, clinical research endeavors and clinical practice overall. These collaborations have done much to promote the reputation of EMCREG and the field of emergency medicine overall.

Over the coming we year we hope to further strengthen our presence with the development of community-endorsed diagnostic and treatment pathways and clinical algorithms, and to finalize our current efforts to standardize the reporting guidelines for acute coronary syndrome within the field of emergency medicine. We are proud of our accomplishments over a relatively short period of time and have every intention of living up to our core values: Investigate | Educate | Collaborate.





Legal information

EMCREG™ - International
4555 Lake Forest Drive
Suite 650
Cincinnati, Ohio 45242

Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)



Advanced Search

5 March 2010
Computed tomography angiography provides important additional prognostic information, but it's role in clinical practice is still not known.
11 February 2010
Researchers report that a novel method for using natriuretic-peptide testing can optimize postdischarge therapy after acute heart-failure decompensation, reduce hospitalization, and improve outcomes.
28 January 2010
Study results show that the TIMI risk score predicts outcomes in emergency department with suspected ACS.
28 January 2010
Serial measurement of NT-proBNP predicts new-onset heart failure and cardiovascular mortality in elderly.
15 January 2010
Results of the PLATO trial show that the reversible P2Y12 inhibitor ticagrelor reduces death and cardiovascular events compared with clopidogrel therapy in ACS patients.
15 January 2010
Individual risk profiling of ACS patients could optimize therapeutic treatment choices.
5 January 2010
Study shows that high sensitive cardiac troponin I level is a useful prognostic marker of mortality in chronic heart failure patients.
23 December 2009
The largest and most comprehensive meta-analysis ever concludes that CRP is unlikely to be a causal factor for cardiovascular disease.
16 December 2009
Research shows that a substantial number of STEMI patients still receive fibrinolytic therapy at PCI capable centers.
11 December 2009
Denmark researchers report in Lancet that relative risk for hospitalization for bleeding increased with all drug combinations and with each additional drug used.
3 December 2009
Researchers report that prehospital triage significantly reduces treatment delay and improves outcomes in STEMI patients who undergo PCI.
30 November 2009
Researchers report that the to reperfusion, beginning with symptom onset time, determines the extent of reversible myocardial injury in STEMI patients undergoing PCI.
NEWS ARCHIVES:
©Copyright EMCREG-International™. All rights reserved